Prospective evaluation of the factors predicting the prognosis of advanced hepatocellular carcinoma (HCC) patients treated with sorafenib.

被引：1
|
作者：
Adachi, Takuya
Nouso, Kazuhiro
Miyahara, Koji
Dohi, Chihiro
Wada, Nozomu
Takeuchi, Yasuto
Kuwaki, Kenji
Onishi, Hideki
Ikeda, Fusao
Nakamura, Shinichiro
Shiraha, Hidenori
Takaguchi, Koichi
Uematsu, Shuji
Iwadou, Shouta
Takuma, Yoshitaka
Hagihara, Hiroaki
Takabatake, Hiroyuki
Takaki, Akinobu
Okada, Hiroyuki
机构：
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan
[2] Okayama Univ, Dept Gastroenterol & Hepatol, Okayama, Japan
[3] Hiroshima City Hiroshima Citizens Hosp, Hiroshima, Japan
[4] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan
[5] Sumitomo Besshi Hosp, Nihama City, Japan
[6] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15674
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15674
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Severe Fatigue is an Important Factor in the Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Qiu, Xuan
    Li, Manjiang
    Wu, Liqun
    Xin, Yang
    Mu, Siyu
    Li, Tianxiang
    Song, Kangjian
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7983 - 7992
  • [22] SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA (HCC) IN PATIENTS WITH ADVANCED LIVER DISEASE
    Alves, Rogerio C.
    Alves, Daniele E.
    Guz, Betty
    Viana, Monica V.
    Harriz, Michelle C.
    Matos, Carla A.
    Terrabuio, Deborah
    Chagas, Aline
    Moutinho, Renata D.
    Taddeo, Eliane F.
    Duarte, Kelly C.
    Oliveira, George P.
    Ribeirol, Juliana M.
    Kondo, Mario
    Gampel, Otavio
    Poletti, Paula
    HEPATOLOGY, 2010, 52 (04) : 1193A - 1193A
  • [23] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitrios
    Thillai, Kiruthikah
    Korantzis, Ippokratis
    Chowdhury, M. H. Ruhe
    Papadatos-Pastos, Dionysios
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [24] Outcomes and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC)
    Ziogas, Dimitris
    Thillai, Kiruthikah
    Papadatos-Pastos, Dionysios
    Chowdhury, Mahfuja Hussain Ruhe
    Korantzis, Ippokratis
    Manickavasagar, Thubeena
    Suddle, Abid
    O'Grady, John
    Heaton, Nigel
    Ross, Paul J.
    Sarker, Debashis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol
    Gardini, Andrea Casadei
    Faloppi, Luca
    Aprile, Giuseppe
    Brunetti, Oronzo
    Caparello, Chiara
    Corbelli, Jody
    Chessa, Luchino
    Bruno, Daniele
    Ercolani, Giorgio
    Leonetti, Alessandro
    de Stefano, Giorgio
    Farella, Nunzia
    Foschi, Francesco Giuseppe
    Lanzi, Arianna
    Dadduzio, Vincenzo
    Marisi, Giorgia
    Masi, Gianluca
    Negri, Francesca, V
    Pagan, Flavia
    Santini, Daniele
    Scarpi, Emanuela
    Silletta, Marianna
    Silvestris, Nicola
    Tamburini, Emiliano
    Tassinari, Davide
    Vivaldi, Caterina
    Gentilucci, Umberto Vespasiani
    Zagonel, Vittorina
    Calvetti, Lorenzo
    Cascinu, Stefano
    Frassineti, Giovanni Luca
    Scartozzi, Mario
    TUMORI JOURNAL, 2018, 104 (06): : 476 - 479
  • [26] CANCER RELATED SYMPTOMS (PERFORMANCE STATUS 0 VS 1) DETERMINE PROGNOSIS OF HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH SORAFENIB. ANALYSIS OF A PROSPECTIVE DATA COLLECTION IN 207 PATIENTS
    Varela, M.
    Reig, M.
    Alvarez Navascues, C.
    Forner, A.
    Cadahia, V.
    Diaz, A.
    Gonzalez-Dieguez, M. L.
    Llarch, N.
    Rodriguez, M.
    Bruix, J.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S454 - S454
  • [27] Development of hand-food skin reaction correlates with prognosis of patients with HCC who were treated with sorafenib.
    Lee, Young-Sun
    Lee, Yoonseok
    Oh, Sang Cheul
    Kim, Ji Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16171 - E16171
  • [28] Early decrease in alfafetoprotein as a prognosis factor of response in patients with advanced hepatocellular carcinoma treated with sorafenib
    Maria Sanchez, Yolanda
    Ontanilla, Guillermo
    Teresa Ferrer, Maria
    Giraldez, Alvaro
    Manuel Sousa, Jose
    Manuel Pascasio, Juan
    HEPATOLOGY, 2016, 64 : 634A - 635A
  • [29] Tumor c-Met expression and prognosis of advanced hepatocellular carcinoma patients treated with sorafenib
    Shao, Yu Yun
    Hsiao, Chi-Huang
    Lee, Ray
    Puig, Oscar
    Chan, Soa-Yu
    Li, Yong-Shi
    Hsu, Chih-Hung
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [30] Prognosis of advanced hepatocellular carcinoma (HCC) in patients undergoing surgery combined with peri- or postoperative treatment with sorafenib
    Wu, Liqun
    Pang, Xufeng
    Cao, Jingyu
    Wang, Zusen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345